Inventor · disambiguated record
Bo Song
Also filed as: SONG BO · SONG BO-JUN
30 granted patents·15 pending applications·280 citations·filing 2002–2024
97Inventor score
Top patents by PatentIndex Score
45 records- 0196US7910088B2Multivalent constructs for therapeutic and diagnostic applicationsBRACCO SUISSE SA·Filed 2007·Granted Mar 22, 2011·24 cites·33 claims
- 0295US7854919B2Multivalent constructs for therapeutic and diagnostic applicationsBRACCO SUISSE SA·Filed 2007·Granted Dec 21, 2010·20 cites·50 claims
- 0394US9056138B2Multivalent constructs for therapeutic and diagnostic applicationsBRACCO SUISSE SA·Filed 2013·Granted Jun 16, 2015·11 cites·22 claims
- 0494US7985402B2Targeting vector-phospholipid conjugatesBRACCO SUISSE SA·Filed 2007·Granted Jul 26, 2011·14 cites·26 claims
- 0594US7261876B2Multivalent constructs for therapeutic and diagnostic applicationsDYAX CORP·Filed 2003·Granted Aug 28, 2007·33 cites·33 claims
- 0694US7211240B2Multivalent constructs for therapeutic and diagnostic applicationsDYAX CORP·Filed 2003·Granted May 1, 2007·52 cites·67 claims
- 0793US7794693B2Targeting vector-phospholipid conjugatesBRACCO INT BV·Filed 2006·Granted Sep 14, 2010·19 cites·26 claims
- 0892US8663603B2Multivalent constructs for therapeutic and diagnostic applicationsARBOGAST CHRISTOPHE·Filed 2010·Granted Mar 4, 2014·12 cites·23 claims
- 0992US8278274B2Fibrin-binding peptides and conjugates thereofBUSSAT PHILIPPE·Filed 2007·Granted Oct 2, 2012·21 cites·57 claims
- 1091US8632753B2Multivalent constructs for therapeutic and diagnostic applicationsFAN HONG·Filed 2010·Granted Jan 21, 2014·12 cites·21 claims
- 1188US8642010B2KDR and VEGF/KDR binding peptides and their use in diagnosis and therapySATO AARON K·Filed 2009·Granted Feb 4, 2014·9 cites·42 claims
- 1287US10377822B2Immunologic effector cell of targeted CLD18A2, and preparation method and use thereofCARSGEN THERAPEUTICS LTD·Filed 2015·Granted Aug 13, 2019·5 cites·13 claims
- 1386US10793641B2Fully human anti-mesothelin antibodies and immune effector cells targeting mesothelinCARSGEN THERAPEUTICS CO LTD·Filed 2016·Granted Oct 6, 2020·5 cites·30 claims
- 1485US11198729B2Immunologic effector cell of targeted CLD18A2, and preparation method and use thereofCAFA THERAPEUTICS LTD·Filed 2019·Granted Dec 14, 2021·3 cites·11 claims
- 1585US8551450B2Targeting vector-phospholipid conjugatesBUSSAT PHILIPPE·Filed 2010·Granted Oct 8, 2013·6 cites·14 claims
- 1684US8623822B2KDR and VEGF/KDR binding peptides and their use in diagnosis and therapyARBOGAST CHRISTOPHE·Filed 2010·Granted Jan 7, 2014·9 cites·10 claims
- 1783US2025230232A1Immunologic effector cell of targeted cld18a2, and preparation method and use thereofCRAGE MEDICAL CO LTD·Filed 2024·Application pending·0 cites
- 1881US8466107B2Fibrin-binding peptides and conjugates thereofBUSSAT PHILIPPE·Filed 2012·Granted Jun 18, 2013·4 cites·27 claims
- 1980US8927207B2miRNAs as therapeutic targets in cancerJU JINGFANG·Filed 2009·Granted Jan 6, 2015·4 cites·6 claims
- 2079US2024342305A1Antibody against glypican-3 and application thereofCRAGE MEDICAL CO LTD·Filed 2024·Application pending·0 cites
- 2178US9381258B2Targeting vector-phospholipid conjugatesBRACCO SUISSE SA·Filed 2013·Granted Jul 5, 2016·2 cites·8 claims
- 2275US12098199B2Immunologic effector cell of targeted CLD18A2, and preparation method and use thereofCRAGE MEDICAL CO LTD·Filed 2021·Granted Sep 24, 2024·0 cites·10 claims
- 2375US9295737B2Targeting vector-phospholipid conjugatesBRACCO SUISSE SA·Filed 2014·Granted Mar 29, 2016·1 cites·6 claims
- 2469US9446155B2KDR and VEGF/KDR binding peptides and their use in diagnosis and therapyDYAX CORP·Filed 2013·Granted Sep 20, 2016·0 cites·20 claims
- 2569US6950093B2Mouse handled in handAIPTEK INT INC·Filed 2002·Granted Sep 27, 2005·14 cites·5 claims
- 2667US2009131636A1Targeting vector-phospholipid conjugatesBRACCO INT BV·Filed 2008·Application pending·0 cites
- 2764US2013266519A1Targeting vector-phospholipid conjugatesBRACCO SUISSE SA·Filed 2013·Application pending·0 cites
- 2864US2022017625A1Tumor-specific anti-egfr antibody and application thereofCAFA THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2963US2015152422A1Mirnas as therapeutic targets in cancerUNIV NEW YORK STATE RES FOUND·Filed 2014·Application pending·0 cites
- 3063US2005100963A1KDR and VEGF/KDR binding peptides and their use in diagnosis and therapyBRACCO INT BV·Filed 2003·Application pending·0 cites
- 3162US2015374843A1Multivalent constructs for therapeutic and diagnostic applicationsBRACCO SUISSE SA·Filed 2015·Application pending·0 cites
- 3260US12168061B2Antibody against glypican-3 and application thereofCRAGE MEDICAL CO LTD·Filed 2016·Granted Dec 17, 2024·0 cites·26 claims
- 3359US9333272B2Fibrin binding peptide conjugates for diagnostic and therapeutic applicationsAIME SILVIO·Filed 2007·Granted May 10, 2016·0 cites·24 claims
- 3458US2016263254A1Targeting vector-phospholipid conjugatesBRACCO SUISSE SA·Filed 2016·Application pending·0 cites
- 3554US10927176B2Tumor-specific anti-EGFR antibody and application thereofCARSGEN THERAPEUTICS CO LTD·Filed 2016·Granted Feb 23, 2021·0 cites·5 claims
- 3654US2011286936A1Targeting vector-phospholipid conjugatesBUSSAT PHILIPPE·Filed 2011·Application pending·0 cites
- 3753US9408926B2KDR and VEGF/KDR binding peptides and their use in diagnosis and therapyBRACCO SUISSE SA·Filed 2013·Granted Aug 9, 2016·0 cites·23 claims
- 3850US2016024597A1miRNAs AS THERAPEUTIC TARGETS IN CANCERUNIV NEW YORK STATE RES FOUND·Filed 2015·Application pending·0 cites
- 3946US2025134102A1Use of flavonoid glycoside in resistance of weeds in riceINST OF BOTANY THE CHINESE ACADEMY OF SCIENCE·Filed 2022·Application pending·0 cites
- 4045US11299525B2Chimeric antigen receptor-modified immune effector cell carrying PD-L1 blocking agentCRAGE MEDICAL CO LTD·Filed 2016·Granted Apr 12, 2022·0 cites·11 claims
- 4144US2005250700A1KDR and VEGF/KDR binding peptidesSATO AARON K·Filed 2004·Application pending·0 cites
- 4244US2012087992A1miRNAS AS THERAPEUTIC TARGETS IN CANCERJU JINGFANG·Filed 2010·Application pending·0 cites
- 4343US6917357B2Handy mouse with a direction-switch deviceAIPTEK INT INC·Filed 2002·Granted Jul 12, 2005·0 cites·5 claims
- 4436US2018105595A1Time and space adjustable system for inhibiting pathological target cellsCARSGEN THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
- 4535US11453860B2GPC3 and ASGPR1 double-targeted transgenic immune effector cell and use thereofCRAGE MEDICAL CO LTD·Filed 2015·Granted Sep 27, 2022·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Bo Song files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →